Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 16, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific transaction event rather than comprehensive financial performance.
Material Changes
A re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan") resulted in an increase in the notional allocation of Ordinary Share ADRs on January 12, 2007. The transaction occurred at a price of $53.75 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly reports a transaction notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Important Facts for Investors
- Transaction Date: January 12, 2007.
- Transaction Price: $53.75 per Ordinary Share ADR.
- Event Type: Increase in notional allocation due to re-valuation of the US Retirement Savings Plan.
- Participants: The notification lists allocations for Dr. J-P Garnier (92 shares), Mr. D Stout (44 shares), Mr. D Phelan (20 shares), Dr. F Calhoun (17 shares), Dr. R G Greig (17 shares), Dr. M M Slaoui (8 shares), Mr. C Viehbacher (8 shares), Dr. D Pulman (6 shares), and Mrs. C Bruck Slaoui (2 shares).